Black Diamond Therapeutics, Inc. (BDTX)
2.40
+0.07
(+3.00%)
USD |
NASDAQ |
Apr 02, 16:00
2.40
0.00 (0.00%)
After-Hours: 16:17
Black Diamond Therapeutics Total Assets (Quarterly) : 143.01M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Bionano Genomics, Inc. | 73.58M |
| IDEAYA Biosciences, Inc. | 1.109B |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.80M |
| Shareholders Equity (Quarterly) | 112.21M |
| Debt to Equity Ratio | 0.1674 |
| Current Ratio | 8.419 |
| Net Debt Paydown Yield | 0.61% |